We are live on ! Find out more

736 hedge funds and large institutions have $7.63B invested in Kyndryl in 2025 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 208 increasing their positions, 198 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

345% more call options, than puts

Call options by funds: $102M | Put options by funds: $22.9M

45% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 83

34% more capital invested

Capital invested by funds: $5.71B → $7.63B (+$1.92B)

5% more funds holding

Funds holding: 703736 (+33)

5% more repeat investments, than reductions

Existing positions increased: 208 | Existing positions reduced: 198

0.5% more ownership

Funds ownership: 78.16%78.66% (+0.5%)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
736
Holders Change
+33
Holders Change %
+4.69%
% of All Funds
9.67%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
120
Increased
208
Reduced
198
Closed
83
Calls
$102M
Puts
$22.9M
Net Calls
+$79.1M
Net Calls Change
+$54.5M

KD Hedge Fund Activity: Q2 2025 in Review

736 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Kyndryl (KD) for Q2 2025, worth a combined $7.63B — up 34% from $5.71B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new KD positions and 83 closed out — a net gain of 37 holders — while 208 added to existing stakes and 198 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $169M. The largest seller was DME Capital Management, cutting an estimated $29.8M.

  • 736 institutional investors held Kyndryl (KD) as of Q2 2025, up from 703 in Q1 2025.
  • Funds reported $7.63B of Kyndryl stock for Q2 2025, up 34% quarter-over-quarter.
  • 120 funds opened new Kyndryl positions in Q2 2025 and 83 closed out, a net change of +37 holders.
  • The largest Kyndryl buyer in Q2 2025 was Fidelity Investments, an estimated $169M added.
  • The largest Kyndryl seller in Q2 2025 was DME Capital Management, an estimated $29.8M sold.

Based on aggregated 13F filings for Q2 2025.